obstructive sleep apnea Clinical Trials and Research
Also known as: sleep apnea, osa, apnea, obstructive sleep apnoea, breathing pauses during sleep, sleep-disordered breathing · ICD-10: G47.33
Obstructive sleep apnea (OSA) is a common condition where breathing repeatedly stops and starts during sleep, leading to disrupted rest and potential health issues. Clinical trial research is focused on developing new therapies, improving diagnostic methods, and understanding its long-term impacts. Find a Trial helps patients search active studies.
Search obstructive sleep apnea trials →
Common questions about obstructive sleep apnea clinical trials
Who can participate in clinical trials for obstructive sleep apnea?
Eligibility criteria vary by study, often including age, OSA severity, and overall health status. Researchers look for participants who fit specific profiles to ensure the study's safety and relevance. Patients can review criteria on ClinicalTrials.gov to understand specific requirements for participation.
What new treatments are being studied for obstructive sleep apnea?
Current research explores novel devices, medications targeting underlying mechanisms, and surgical approaches beyond traditional options like CPAP. Studies funded by NIH RePORTER and listed on ClinicalTrials.gov investigate ways to improve breathing and sleep quality for patients with OSA.
What are the different phases of clinical trials for OSA?
Clinical trials for OSA progress through phases, starting with small safety studies (Phase 1), then larger efficacy trials (Phase 2 and 3), and finally post-market surveillance (Phase 4). Each phase gathers specific data on new interventions, as detailed on ClinicalTrials.gov.
Beyond CPAP, what other interventions are being investigated in OSA trials?
Researchers are studying oral appliances, nerve stimulation devices, weight management programs, and various drug therapies to address OSA. These interventions aim to improve airway patency or reduce respiratory events during sleep, as seen in studies on ClinicalTrials.gov and NIH RePORTER.
Do clinical trials for obstructive sleep apnea cost money to participate?
Generally, participants do not pay for study-related treatments or tests in clinical trials. Some trials may even offer compensation for time and travel. Specific financial details are outlined in the informed consent document for each study, available on ClinicalTrials.gov.
Are there specific biomarkers researchers look for in OSA clinical trials?
Researchers often look at biomarkers related to inflammation, metabolic health, and cardiovascular risk, as well as sleep study metrics like AHI (Apnea-Hypopnea Index). These help assess OSA severity, treatment response, and long-term health impacts, according to data from NIH RePORTER.
What might prevent someone from joining an OSA clinical trial?
Common exclusion criteria can include certain co-existing medical conditions, specific medication use, or previous unsuccessful treatments for OSA. These criteria ensure participant safety and the study's focus, as detailed in trial listings on ClinicalTrials.gov and study protocols.
What are the potential benefits and risks of participating in an OSA clinical trial?
Potential benefits include access to new treatments and close medical monitoring. Risks can involve side effects from new interventions or the inconvenience of study procedures. All potential benefits and risks are thoroughly explained in the informed consent process, per ClinicalTrials.gov guidelines.
How to find a obstructive sleep apnea trial that fits you
- Describe your obstructive sleep apnea situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all obstructive sleep apnea trials →